GlassScriptPhysician profile
James C Thompson
NPI 1881666790
$11,117.74
in general payments reported to CMS, 2019-2025
52 companies · $1,848 in 2025
The $1,848 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,303 · 2020: $1,048 · 2021: $1,498 · 2022: $1,416 · 2023: $2,019 · 2024: $986 · 2025: $1,848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,853.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,573.03 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $1,467.68 | 2020-2025 | Linzess, Vraylar, Ubrelvy |
| Pfizer INC. | $1,456.39 | 2019-2025 | |
| Novo Nordisk INC | $770.42 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $641.78 | 2019-2025 | Evenity, Prolia, Otezla |
| Astellas Pharma US INC | $524.95 | 2019-2025 | Veozah, Myrbetriq |
| Lilly USA, LLC | $405.92 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $390.01 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Sanofi-Aventis U.S. LLC | $385.33 | 2019-2025 | |
| Glaxosmithkline, LLC. | $297.12 | 2019-2021 | |
| Amarin Pharma, INC. | $290.32 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $265.99 | 2019-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $205.83 | 2019-2024 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $185.38 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $173.47 | 2019-2023 | Trintellix |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $167.83 | 2019-2020 | |
| Verona Pharma, INC. | $135.61 | 2025 | Ohtuvayre |
| Daiichi Sankyo INC. | $122.06 | 2019-2025 | Injectafer |
| Neurocrine Biosciences, INC. | $122.04 | 2022-2025 | Ingrezza, Ongentys |
| Dexcom, INC. | $114.94 | 2021-2023 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $108.95 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $104.72 | 2022-2025 | |
| Eisai INC. | $103.88 | 2021-2025 | |
| Esperion Therapeutics, INC. | $99.65 | 2020-2024 | Nexletol |
| Exact Sciences Corporation | $87.83 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $82.27 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $79.29 | 2019-2023 | Gardasil 9, Vaxneuvance |
| Phathom Pharmaceuticals, INC. | $76.21 | 2024-2025 | Voquezna |
| Lundbeck LLC | $76.13 | 2023-2025 | Vyepti, Rexulti |
| Dynavax Technologies Corporation | $65.75 | 2023-2024 | Heplisav-B |
| Antares Pharma, INC. | $53.17 | 2022-2025 | Xyosted |
| Kowa Pharmaceuticals America, INC. | $48.34 | 2020-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $37.42 | 2025 | Caplyta |
| Inspire Medical Systems, INC. | $36.79 | 2025 | Inspire |
| Axsome Therapeutics, INC. | $35.98 | 2025 | Symbravo, Auvelity |
| E.R. Squibb & Sons, L.L.C. | $35.76 | 2022-2023 | Eliquis |
| Sanofi Pasteur INC. | $35.21 | 2019-2021 | |
| Bausch Health US, LLC | $31.73 | 2019 | |
| Medtronic, INC. | $23.15 | 2025 | Intellis Adaptivestim |
| Teva Pharmaceuticals USA, INC. | $19.90 | 2022 | |
| Mayne Pharma Commercial LLC | $19.57 | 2025 | |
| Hikma Pharmaceuticals USA | $16.42 | 2024 | Ryaltris |
| Alnylam Pharmaceuticals INC. | $16.23 | 2023 | Onpattro |
| Tolmar, INC. | $15.61 | 2025 | Jatenzo |
| Mylan Specialty L.P. | $15.59 | 2019 | |
| Edwards Lifesciences Corporation | $15.48 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Idorsia Pharmaceuticals US INC | $15.18 | 2023 | Quviviq |
| Alexion Pharmaceuticals, INC. | $14.28 | 2022 | |
| Intuity Medical INC | $13.20 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Currax Pharmaceuticals LLC | $13.17 | 2023 | Onzetra Xsail, Nexletol, Contrave |
| Ironshore Pharmaceuticals INC. | $12.49 | 2019 | |
| Almatica Pharma LLC | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.